Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenmai Shuxin Dropping Pills vs Shengmai Capsules for Stable Angina (Qi and Yin Deficiency)
CTR20130345Phase 3Active
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Nov 2015
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Shenmai Shuxin in coronary arteriosclerosis, angina pectoris, sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Nov 2015; status: active.
02
Drugs
Shenmai Shuxin
03
Conditions
coronary arteriosclerosisangina pectoris
Beyond the preview
Go deeper on CTR20130345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130345.